Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen M McDonagh

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Nature Reviews. Drug Discovery|December 17, 2024
Open Targets: 10 years of partnership in target discoveryDavid G Hulcoop, Gosia Trynka, Ellen M McDonagh
Pharmacogenetics and Genomics|December 17, 2014
PharmGKB summary: very important pharmacogene information for CFTREllen M McDonagh, John P Clancy, Russ B Altman, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 31, 2026
The Potential of Digital Twins for Pediatric Rare DiseasesRahuman S Malik-Sheriff, Anurag Limdi, Evangelia Petsalaki, et al.
Nature Reviews. Drug Discovery|July 8, 2022
Human genetics evidence supports two-thirds of the 2021 FDA-approved drugsDavid Ochoa, Mohd Karim, Maya Ghoussaini, et al.
Pharmacogenetics and Genomics|August 6, 2013
PharmGKB summary: methylene blue pathwayEllen M McDonagh, José M Bautista, Ilan Youngster, et al.
Pharmacogenetics and Genomics|February 2, 2012
PharmGKB summary: caffeine pathwayCaroline F Thorn, Eleni Aklillu, Ellen M McDonagh, et al.
Biomarkers in Medicine|November 23, 2011
From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resourceEllen M McDonagh, Michelle Whirl-Carrillo, Yael Garten, et al.
Pharmacogenetics and Genomics|May 14, 2015
PharmGKB summary: Efavirenz pathway, pharmacokineticsEllen M McDonagh, Johnathan L Lau, Maria L Alvarellos, et al.
Pharmacogenetics and Genomics|June 11, 2014
PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamicsEllen M McDonagh, Caroline F Thorn, John T Callaghan, et al.
Pharmacogenetics and Genomics|June 4, 2014
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2Ellen M McDonagh, Sotiria Boukouvala, Eleni Aklillu, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Nature Reviews. Drug Discovery|December 17, 2024
Open Targets: 10 years of partnership in target discoveryDavid G Hulcoop, Gosia Trynka, Ellen M McDonagh
Pharmacogenetics and Genomics|December 17, 2014
PharmGKB summary: very important pharmacogene information for CFTREllen M McDonagh, John P Clancy, Russ B Altman, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 31, 2026
The Potential of Digital Twins for Pediatric Rare DiseasesRahuman S Malik-Sheriff, Anurag Limdi, Evangelia Petsalaki, et al.
Nature Reviews. Drug Discovery|July 8, 2022
Human genetics evidence supports two-thirds of the 2021 FDA-approved drugsDavid Ochoa, Mohd Karim, Maya Ghoussaini, et al.
Pharmacogenetics and Genomics|August 6, 2013
PharmGKB summary: methylene blue pathwayEllen M McDonagh, José M Bautista, Ilan Youngster, et al.
Pharmacogenetics and Genomics|February 2, 2012
PharmGKB summary: caffeine pathwayCaroline F Thorn, Eleni Aklillu, Ellen M McDonagh, et al.
Biomarkers in Medicine|November 23, 2011
From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resourceEllen M McDonagh, Michelle Whirl-Carrillo, Yael Garten, et al.
Pharmacogenetics and Genomics|May 14, 2015
PharmGKB summary: Efavirenz pathway, pharmacokineticsEllen M McDonagh, Johnathan L Lau, Maria L Alvarellos, et al.
Pharmacogenetics and Genomics|June 11, 2014
PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamicsEllen M McDonagh, Caroline F Thorn, John T Callaghan, et al.
Pharmacogenetics and Genomics|June 4, 2014
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2Ellen M McDonagh, Sotiria Boukouvala, Eleni Aklillu, et al.
Pageof 5